NewsDesk @bactiman63 Today, the Africa CDC published a press release on the latest Ebola outbreak in Equateur Province, Democratic Republic of Congo, which offered some additional details on the case: The...

By NewsDesk  @infectiousdiseasenews Johnson & Johnson’s two-dose Ebola vaccine regimen is safe, well tolerated and produces a strong immune response in people over the age of one, according to...

By NewsDesk  @bactiman63 As of Thursday, the World Health Organization (WHO) has reported nine confirmed and probable Ebola Virus Disease (EVD) cases, including five deaths. While no confirmed cases...

By NewsDesk  @bactiman63 Health authorities in Guinea declared an Ebola outbreak on 14 February after three cases detected in Gouécké, a rural community in N’Zerekore prefecture tested positive for...

GeoVax Labs, Inc., a biotechnology company developing human vaccines and immunotherapies against infectious diseases and cancer, announced today a multi-party collaboration for the development of Sudan...

By NewsDesk  @infectiousdiseasenews Since our last report on June 30, four additional Ebola Virus Disease (EVD) cases and one death has been reported in the outbreak in the Democratic Republic of the...

By NewsDesk  @infectiousdiseasenews In an update on the Ebola virus disease (EVD) outbreak in the Democratic Republic of the Congo (DRC), no new cases were reported during the week May 20-26. Since the...

The Sabin Vaccine Institute (Sabin) and its partner ReiThera Srl today announced that the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for...

Infectious disease scientists report early development of a potential universal vaccine for Ebola viruses that preclinical tests show might neutralize all four species of these deadly viruses infecting...

Merck announced Friday that four African countries, including the Democratic Republic of the Congo (DRC), Burundi, Ghana, and Zambia, have approved the Ebola Zaire Vaccine, ERVEBO. Approvals by these...